Authors

is senior vice president and practice lead for clinical and regulatory services at Lumanity, partnering with biopharma companies to shape clinical development and regulatory strategies from early development through approval and lifecycle management. With decades of experience spanning academia, biotech, and consulting, she has helped organizations navigate complex development and evidence-generation challenges, align stakeholders, and translate scientific innovation into clear development pathways.

CEO of ZS. He has served in the CEO role since July 2021. Prior to this, Khedkar led the firm’s global pharmaceuticals practice for nine years, as well as a practice focused on the dynamics of healthcare ecosystems. He founded and led its advanced data science capability track, which focuses on AI. He has also served on ZS’s board since 2012.

Khedkar has advised numerous leading companies in the pharmaceutical and healthcare industries on a wide range of sales and marketing issues, including market access and managed care, using AI for multichannel marketing, marketing mix, sales force strategy, and incentive compensation. More recently, his work has focused on developing effective strategies and analytics for changing customers in the new healthcare ecosystem.

A recognized healthcare industry expert, Pratap regularly contributes his insights to publications including Pharmaceutical Executive, The Wall Street Journal, Bloomberg Businessweek, Business Insider, Fortune, Medical Marketing & Media, NPR, and others. His thought leadership work focuses on topics as diverse as healthcare policy; life sciences companies’ new commercial and organizational models; and the evolving relationships between patients, providers, and payers and the life sciences organizations that serve them.

Holger Liebig

Executive Director, Partnership Center of Excellence, Parexel International

Steve Callahan is the senior director of Advisory & Insights at MMIT, managing several syndicated and episodic products, which synthesize actionable insights from a variety of healthcare decision-makers to inform key decisions and use cases. He holds an M.S. in biology from Fairfield University and an MBA from the University of Connecticut.